Motherisk Rounds: Risks of Statin Use During Pregnancy: A Systematic Review
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 29 (11) , 906-908
Abstract
No abstract availableKeywords
Funding Information
- Hospital for Sick Children
This publication has 15 references indexed in Scilit:
- Risk of congenital anomalies in pregnant users of statin drugsBritish Journal of Clinical Pharmacology, 2007
- Who should receive a statin these days? Lessons from recent clinical trialsJournal of Internal Medicine, 2006
- 2005 Josef Warkany lecture: CliniciansBirth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Pregnancy outcomes after maternal exposure to simvastatin and lovastatinBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Simvastatin has deleterious effects on human first trimester placental explantsHuman Reproduction, 2005
- Central Nervous System and Limb Anomalies in Case Reports of First-Trimester Statin ExposureNew England Journal of Medicine, 2004
- Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancyReproductive Toxicology, 1996
- HMG-CoA reductase inhibitors: role in normal and malignant cellsCritical Reviews in Oncology/Hematology, 1996
- Developmental toxicity of the HMG‐CoA reductase inhibitor, atorvastatin, in rats and rabbitsTeratology, 1994
- Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductaseTeratology, 1983